IL6 and breast carcinoma: This result was consistent with our previous findings that, among all determined inflammatory biomarkers (IL-1β, IL-6, TNF-α, and CRP), only TNF-α significantly mediated the relationship between the E-DII and DepS in breast cancer patients [26].